Is COVID-19 receiving ADE from other coronaviruses?

Microbes and Infection

Volumn 22, Issue 2, 2020, Pages 72-73

  Tetro, Jason A ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

Antibody dependent enhancement; Coronavirus; COVID 19

Indexed keywords

EPITOPE; COVID-19; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2;

2019 NOVEL CORONAVIRUS; ADULT RESPIRATORY DISTRESS SYNDROME; ANTIBODY DEPENDENT ENHANCEMENT; ARTICLE; CORONAVIRINAE; CORONAVIRUS DISEASE 2019; CORONAVIRUS INFECTION; CYTOKINE STORM; EPIDEMIC; IMMUNE RESPONSE; PRIORITY JOURNAL; SARS CORONAVIRUS; SEROCONVERSION; SEROPREVALENCE; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; BETACORONAVIRUS; CHINA; EPIDEMIOLOGY; HUMAN; IMMUNOLOGY; MEDICAL GEOGRAPHY; MORTALITY; PANDEMIC; PATHOGENICITY; PATHOLOGY; VIRUS PNEUMONIA;

ANTIBODY-DEPENDENT ENHANCEMENT; BETACORONAVIRUS; CHINA; CORONAVIRUS INFECTIONS; GEOGRAPHY, MEDICAL; HUMANS; PANDEMICS; PNEUMONIA, VIRAL;

EID: 85080070481     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2020.02.006     Document Type: Article

References (18)

1. Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395:10223 (2020), 507–513 pii: S0140-6736(20)30211-7.
2. Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395:10223 (2020), 497–506 pii: S0140-6736(20)30183-5.
3. Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. J Am Med Assoc, 2020, 10.1001/jama.2020.1585.
4. Cheung, C.Y., Poon, L.L.M., Ng, I.H.Y., Luk, W., Sia, S.-F., Wu, M.H.S., et al. Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis. J Virol 79 (2005), 7819–7826.
5. New coronavirus may be no more dangerous than the flu despite worldwide alarm: experts. [Internet] Natl Post, 2020 [cited 2020 Feb 9]. Available from: https://nationalpost.com/health/new-coronavirus-may-be-no-more-dangerous-than-the-flu-despite-worldwide-alarm-experts.
6. Yang, Z.Y., Werner, H.C., Kong, W.P., Leung, K., Traggiai, E., Lanzavecchia, A., et al. Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses. Proc Natl Acad Sci U S A 102 (2005), 797–801.
7. Ho, M.S., Chen, W.J., Chen, H.Y., Lin, S.F., Wang, W.C., Di, J., et al. Neutralizing antibody response and SARS severity. Emerg Infect Dis 11 (2005), 1730–1737.
8. Yip, M.S., Leung, N.H., Cheung, C.Y., Li, P.H., Lee, H.H.Y., Daëron, M., et al. Antibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirus. Virol J, 11, 2014, 82.
9. Jaume, M., Yip, M.S., Cheung, C.Y., Leung, H.L., Li, P.H., Kien, F., et al. Anti-severe acute respiratory syndrome coronavirus spike antibodies trigger infection of human immune cells via a pH- and cysteine protease-independent FcγR pathway. J Virol 85 (2011), 10582–10597.
10. Wang, S.F., Tseng, S.P., Yen, C.H., Yang, J.Y., Tsao, C.H., Shen, C.W., et al. Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins. Biochem Biophys Res Commun 451 (2014), 208–214.
11. Yoshikawa, T., Hill, T., Li, K., Peters, C.J., Tseng, C.-T.K., Severe acute respiratory syndrome (SARS) coronavirus-induced lung epithelial cytokines exacerbate SARS pathogenesis by modulating intrinsic functions of monocyte-derived macrophages and dendritic cells. J Virol 83 (2009), 3039–3048.
12. Channappanavar, R., Fehr, A.R., Vijay, R., Mack, M., Zhao, J., Meyerholz, D.K., et al. Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice. Cell Host Microbe 19 (2016), 181–193.
13. Donnelly, C.A., Fisher, M.C., Fraser, C., Ghani, A.C., Riley, S., Ferguson, N.M., et al. Epidemiological and genetic analysis of severe acute respiratory syndrome. Lancet Infect Dis 4 (2004), 672–683.
14. Gorbalenya, A.E., Severe acute respiratory syndrome-related coronavirus – the species and its viruses, a statement of the Coronavirus Study Group. BioRxiv, 2020, 10.1101/2020.02.07.937862.
15. Lu, R., Zhao, X., Li, J., Niu, P., Yang, B., Wu, H., et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet(20), 2020, 30251–30258 pii: S0140-6736.
16. Hua, R., Zhou, Y., Wang, Y., Hua, Y., Tong, G., Identification of two antigenic epitopes on SARS-CoV spike protein. Biochem Biophys Res Commun 319 (2004), 929–935.
17. Leung, G.M., Lim, W.W., Ho, L.M., Lam, T.H., Ghani, A.C., Donnelly, C.A., et al. Seroprevalence of IgG antibodies to SARS-coronavirus in asymptomatic or subclinical population groups. Epidemiol Infect 134 (2006), 211–221.
18. Wu, Z., Yang, L., Ren, X., He, G., Zhang, J., Yang, J., et al. Deciphering the bat virome catalog to better understand the ecological diversity of bat viruses and the bat origin of emerging infectious diseases. ISME J 10 (2016), 609–620.